CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-07-15 | Wu Xiaobin President & GM China | Sale | −300 | $242.63 | $73K | 400 |
| 2020-07-15 | Wu Xiaobin President & GM China | Sale | −200 | $243.91 | $49K | 200 |
| 2020-07-15 | Wu Xiaobin President & GM China | Sale | −200 | $246.10 | $49K | 0 |
| 2020-07-13 | Wu Xiaobin President & GM China | Sale | −3,000 | $220.00 | $660K | 0 |
| 2020-07-08 | OYLER JOHN Chief Executive Officer | Sale | −600 | $196.51 | $118K | 16,929 |
| 2020-07-08 | OYLER JOHN Chief Executive Officer | Sale | −700 | $197.98 | $139K | 16,229 |
| 2020-07-08 | OYLER JOHN Chief Executive Officer | Sale | −1,800 | $199.26 | $359K | 14,429 |
| 2020-07-08 | OYLER JOHN Chief Executive Officer | Sale | −2,900 | $200.55 | $582K | 11,529 |
| 2020-07-08 | OYLER JOHN Chief Executive Officer | Sale | −4,841 | $201.58 | $976K | 6,688 |
| 2020-07-08 | OYLER JOHN Chief Executive Officer | Sale | −3,834 | $202.37 | $776K | 2,854 |
| 2020-07-08 | OYLER JOHN Chief Executive Officer | Sale | −2,854 | $203.81 | $582K | 0 |
| 2020-07-07 | Wang Xiaodong Director | Sale | −6,000 | $200.00 | $1.2M | 0 |
| 2020-07-07 | Huang Jane CMO, Hematology | Option exercise | +3,921 | $160.40 | $629K | 3,921 |
| 2020-07-07 | Huang Jane CMO, Hematology | Sale | −3,921 | $200.00 | $784K | 0 |
| 2020-07-07 | Huang Jane CMO, Hematology | Option exercise · Share Option (Right to Buy) | −50,973 | 232,180 | ||
| 2020-07-07 | OYLER JOHN Chief Executive Officer | Sale | −3,730 | $196.82 | $734K | 15,293 |
| 2020-07-07 | OYLER JOHN Chief Executive Officer | Sale | −1,501 | $197.80 | $297K | 13,792 |
| 2020-07-07 | OYLER JOHN Chief Executive Officer | Sale | −5,474 | $199.01 | $1.1M | 8,318 |
| 2020-07-07 | OYLER JOHN Chief Executive Officer | Sale | −8,318 | $199.88 | $1.7M | 0 |
| 2020-07-06 | OYLER JOHN Chief Executive Officer | Sale | −800 | $195.43 | $156K | 16,562 |
Page 90 of 99 · 1,972 trades